[DOI] [PubMed] [Google Scholar] 203.Bjorbaek C, Elmquist JK, Michl P, Ahima RS, van Bueren A, McCall AL, et al
According to the World Health Organization (WHO), it is estimated that around 77 million adults are presently living with type 2 diabetes and nearly 25 million are classified as prediabetic
Science-Backed How Tirzepatide works Tirzepatide is a first-in-class dual-agonist, activating both GLP-1 and GIP hormone receptors to powerfully regulate appetite, blood sugar, and fat metabolism
Meet with your specialist to review your health history, goals, and lab results
Our healthcare professionals work closely with you to develop a customized treatment plan that aligns with your specific needs and goals